CCL20 has become of great interest in tumor research as it promotes tumor progression in different solid tumor entities, including cervical carcinoma, pancreatic ductal adenocarcinoma, cutaneous squamous cell carcinoma and breast cancer [11,12,13,14]. This evidence concerns the gene CCL20 and pancreatic ductal adenocarcinoma.